Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl- phenyl)-piperazin-1-yl]-dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic pain in mice

Pharmacology Biochemistry and Behavior

Volumn 122, Issue , 2014, Pages 173-181

  Sałat, Kinga ^a   Cios, Agnieszka ^a   Wyska, Elzbieta ^a   Sałat, Robert ^b   Mogilski, Szczepan ^a   Filipek, Barbara ^a   Wiȩckowski, Krzysztof ^a   Malawska, Barbara ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Chemotherapy induced neuropathic pain; Dihydrofuran 2 one; Pain threshold; Pharmacokinetics; Pregabalin; Transient Receptor Potential channels

Indexed keywords

3 [4 (3 TRIFLUOROMETHYL-PHENYL) PIPERAZIN 1 YL] DIHYDROFURAN 2 ONE; ALLYL ISOTHIOCYANATE; ANALGESIC AGENT; CAPSAICIN; CAPSAZEPINE; OXALIPLATIN; PACLITAXEL; PREGABALIN; UNCLASSIFIED DRUG; 3-(4-(3-TRIFLUOROMETHYLPHENYL)PIPERAZIN-1-YL)DIHYDROFURAN-2-ONE; 4 AMINOBUTYRIC ACID; ANTINEOPLASTIC AGENT; GAMMA BUTYROLACTONE; PIPERAZINE DERIVATIVE;

ADULT; ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIALLODYNIC ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; EXPERIMENTAL CHEMOTHERAPY-INDUCED NEUROPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERALGESIA; LATENT PERIOD; LOCOMOTION; MALE; MECHANICAL STIMULATION; MOTOR COORDINATION; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; ROTAROD TEST; SCIATIC NERVE; SEDATION; TARGET ORGAN; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; HEAT; NEURALGIA; PAIN MEASUREMENT; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TOUCH; TOXICITY;

4-BUTYROLACTONE; ANALGESICS; ANIMALS; ANTINEOPLASTIC AGENTS; GAMMA-AMINOBUTYRIC ACID; HOT TEMPERATURE; HYPERALGESIA; MALE; MICE; NEURALGIA; PAIN MEASUREMENT; PIPERAZINES; TOUCH;

EID: 84899582261     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.03.025     Document Type: Article

References (28)

1. N. Authier, D. Balayssac, F. Marchand, B. Ling, A. Zangarelli, and J. Descoeur et al. Animal models of chemotherapy-evoked painful peripheral neuropathies Neurotherapeutics 6 4 2009 620 629
2. M.M. Backonja Defining neuropathic pain Anesth Analg 97 3 2003 785 790
3. J. Chen, S.K. Joshi, S. DiDomenico, R.J. Perner, J.P. Mikusa, and D.M. Gauvin et al. Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation Pain 152 5 2011 1165 1172
4. M.T. Fallon Neuropathic pain in cancer Br J Anaesth 111 1 2013 105 111
5. N.B. Finnerup, M. Otto, H.J. McQuay, T.S. Jensen, and S.H. Sindrup Algorithm for neuropathic pain treatment: an evidence based proposal Pain 118 3 2005 289 305 (Pubitemid 41752987)
6. S.J. Flatters, W.H. Xiao, and G.J. Bennett Acetyl-l-carnitine prevents and reduces paclitaxel induced painful peripheral neuropathy Neurosci Lett 397 3 2006 219 223
7. B. Gagnon, A. Almahrezi, and G. Schreier Methadone in the treatment of neuropathic pain Pain Res Manag 8 2003 149 154 (Pubitemid 37461198)
8. P. Gauchan, T. Andoh, A. Kato, and Y. Kuraishi Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice Neurosci Lett 458 2 2009 93 95 10.1016/j.neulet.2009.04. 029
9. I. Gilron, J.M. Bailey, D. Tu, R.R. Holden, D.F. Weaver, and R.L. Houlden Morphine, gabapentin, or their combination for neuropathic pain N Engl J Med 352 13 2005 1324 1334 (Pubitemid 40411499)
10. T. Hara, T. Chiba, K. Abe, A. Makabe, S. Ikeno, and K. Kawakami et al. Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion Pain 154 6 2013 882 889
11. K.Y. Kwan, A.J. Allchorne, M.A. Vollrath, A.P. Christensen, D.S. Zhang, and C.J. Woolf et al. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction Neuron 50 2 2006 277 289
12. J.T. Litchfield, and E. Wilcoxon A simplified method of evaluating dose-effect experiments J Pharmacol Exp Ther 96 1949 99 113
13. S. Materazzi, C. Fusi, S. Benemei, P. Pedretti, R. Patacchini, and B. Nilius et al. TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism Pflugers Arch 463 4 2012 561 569
14. R. Nassini, M. Gees, S. Harrison, G. De Siena, S. Materazzi, and N. Moretto et al. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation Pain 152 7 2011 1621 1631
15. D. Pascual, C. Goicoechea, E. Burgos, and M.I. Martín Antinociceptive effect of three common analgesic drugs on peripheral neuropathy induced by paclitaxel in rats Pharmacol Biochem Behav 95 3 2010 331 337
16. P. Peng, Q. Xi, S. Xia, L. Zhuang, Q. Gui, and Y. Chen et al. Pregabalin attenuates docetaxel-induced neuropathy in rats J Huazhong Univ Sci Technolog Med Sci 32 4 2012 586 590
17. M. Pevida, A. Lastra, A. Hidalgo, A. Baamonde, and L. Menéndez Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia Brain Res Bull 95 2013 21 27
18. C.L. Renn, V.A. Carozzi, P. Rhee, D. Gallop, S.G. Dorsey, and G. Cavaletti Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice Mol Pain 7 2011 29
19. M.W. Saif, K. Syrigos, K. Kaley, and I. Isufi Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy Anticancer Res 30 7 2010 2927 2933
20. R. Salat, and K. Salat The application of support vector regression for prediction of the antiallodynic effect of drug combinations in the mouse model of streptozocin-induced diabetic neuropathy Comput Methods Programs Biomed 111 2 2013 330 337
21. K. Salat, T. Librowski, A. Moniczewski, K. Stanisz-Wallis, K. Wieckowski, and B. Malawska Analgesic, antioedematous and antioxidant activity of γ-butyrolactone derivatives in rodents Behav Pharmacol 23 4 2012 407 416
22. K. Salat, A. Moniczewski, R. Salat, M. Janaszek, B. Filipek, and B. Malawska et al. Analgesic, anticonvulsant and antioxidant activities of 3-[4-(3-trifluoromethyl-phenyl)piperazin-1-yl] dihydrofuran-2-one dihydrochloride in mice Pharmacol Biochem Behav 101 1 2012 138 147
23. K. Sałat, B. Filipek, K. Wieckowski, and B. Malawska Analgesic activity of 3-mono-substituted derivatives of dihydrofuran-2-one in experimental rodent models of pain Pharmacol Rep 61 5 2009 807 818
24. K. Sałat, K. Gawlik, J. Witalis, D. Pawlica-Gosiewska, B. Filipek, and B. Solnica et al. Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethylphenyl)-piperazin-1-yl] dihydrofuran-2-one in mice Naunyn Schmiedebergs Arch Pharmacol 386 6 2013 493 505
25. K. Sałat, A. Moniczewski, and T. Librowski Transient receptor potential channels - emerging novel drug targets for the treatment of pain Curr Med Chem 20 11 2013 1409 1436
26. K. Sałat, M. Głuch-Lutwin, B. Nawieśniak, K. Gawlik, D. Pawlica-Gosiewska, and J. Witalis et al. Influence of analgesic active 3-[4-(3-trifluoromethyl phenyl)-piperazin-1-yl]-dihydrofuran-2-one on the antioxidant status, glucose utilization and lipid accumulation in some in vitro and ex vivo assays Toxicol Mech Methods 24 3 2014 204 211
27. W.H. Xiao, H. Zheng, and G.J. Bennett Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel Neuroscience 203 2012 194 206
28. M. Zhao, K. Isami, S. Nakamura, H. Shirakawa, T. Nakagawa, and S. Kaneko Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice Mol Pain 8 2012 55